Showing 12 of 29 posts with this tag
Nieng Yan, a well-known Chinese structural biologist, responded on Twitter-like Weibo on November 11 to topics such as her resignation from Princeton University, her return to China, and her core research direction being replaced by AI.
Biocytogen, an emerging pharmaceutical technology company, announced today that it has completed a new round of funding worth tens of millions of dollars, jointly led by Lake Bleu Capital, China Pinnacle Equity Management, Octagon Capital and OrbiMed.
Last week saw two prominent Chinese VC funds – Future Capital and Qiming Venture Partners – raise new US dollar funds.
Sironax, an emerging biotechnology company, announced on August 2 its completion of round-B financing, bringing the firm's total fundraising to more than $300 million.
On December 10, Nieng Yan, a well-known Chinese structural biologist who recently resigned as a professor at Princeton University and returned to China, was appointed as the dean of Shenzhen Medical Academy of Research and Translation.
Chinese unmanned retail solution provider SandStar announced that it has raised hundreds of millions of yuan in a series B+ round of financing.
Beijing-based tech giant and TikTok owner ByteDance has recently ventured into the life sciences sector. Last October, the firm invested in biotech startup Shuimu BioSciences.
Biotechnology startup MobiDrop completed an A+ round of financing worth nearly 100 million yuan ($14.8 million). The funding was led by LYFE Capital, followed by existing shareholder Source Code Capital and local government guidance entity Yunxiang Fund.
Mojia Biotech has recently completed round-B financing worth over $80 million, led by Temasek and followed by Santo Investment and LYZZ Capital.
Life sciences company BioMap was formally announced on Sept. 25, led by Baidu CEO Robin Li as chairman and Baidu Ventures (BV) CEO Liu Wei as co-founder and CEO.
Gracell Biotechnologies raises $100 million in Series C round.
New Horizon Health on Nov. 25 announced that their flagship product, ColoClear, has been approved by the National Medical Products Administration for the screening of Colorectal Cancer (CRC) and precancerous lesion.